mCRPC

Open Access
Prostate-Specific Membrane Antigen Expression on PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer: A Retrospective Observational Study
Letizia Calderoni, Elisa Maietti, Andrea Farolfi, Riccardo Mei, Karly S. Louie, Michael Groaning and Stefano Fanti

Journal of Nuclear Medicine June 1, 2023, 64 (6) 910-917; DOI: https://doi.org/10.2967/jnumed.122.264964
You have access
[¹⁷⁷Lu]Lu-PSMA-Radioligand Therapy Efficacy Outcomes in Taxane-Naïve Versus Taxane-Treated Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Metaanalysis
Swayamjeet Satapathy, Ranjit K. Sahoo and Chandrasekhar Bal

Journal of Nuclear Medicine May 11, 2023, 265414; DOI: https://doi.org/10.2967/jnumed.123.265414
You have access
Using ⁶⁸Ga-PSMA-11 PET/CT for Therapy Response Assessment in Patients with Metastatic Castration-Resistant Prostate Cancer: Application of EAU/EANM Recommendations in Clinical Practice
Chloé S. Denis, François Cousin, Bram De Laere, Roland Hustinx, Brieuc R. Sautois and Nadia Withofs

Journal of Nuclear Medicine December 1, 2022, 63 (12) 1815-1821; DOI: https://doi.org/10.2967/jnumed.121.263611
You have access
Pretherapeutic Comparative Dosimetry of ¹⁷⁷Lu-rhPSMA-7.3 and ¹⁷⁷Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, Robert Tauber, Jakob Allmann, Lisa Steinhelfer, Isabel Rauscher, Alexander Wurzer, Hans-Jürgen Wester, Wolfgang A. Weber, Calogero d’Alessandria and Matthias Eiber

Journal of Nuclear Medicine June 1, 2022, 63 (6) 833-839; DOI: https://doi.org/10.2967/jnumed.121.262671
You have access
Liver Enzyme Elevation After ¹⁷⁷Lu-PSMA Radioligand Therapy for Metastasized Castration-Resistant Prostate Cancer
Hannes Treiber, Alexander König, Albrecht Neesse, Annika Richter, Carsten Oliver Sahlmann and Arne Strauss

Journal of Nuclear Medicine July 1, 2021, 62 (7) 1016-1019; DOI: https://doi.org/10.2967/jnumed.120.258533
You have access
Assessing Radiographic Response to ²²³Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients
Aseem Anand, Elin Trägårdh, Lars Edenbrandt, Lars Beckman, Jan-Henry Svensson, Camilla Thellenberg, Anders Widmark, Jon Kindblom, Anders Ullén and Anders Bjartell

Journal of Nuclear Medicine May 1, 2020, 61 (5) 671-675; DOI: https://doi.org/10.2967/jnumed.119.231100
You have access
German Multicenter Study Investigating ¹⁷⁷Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
Kambiz Rahbar, Hojjat Ahmadzadehfar, Clemens Kratochwil, Uwe Haberkorn, Michael Schäfers, Markus Essler, Richard P. Baum, Harshad R. Kulkarni, Matthias Schmidt, Alexander Drzezga, Peter Bartenstein, Andreas Pfestroff, Markus Luster, Ulf Lützen, Marlies Marx, Vikas Prasad, Winfried Brenner, Alexander Heinzel, Felix M. Mottaghy, Juri Ruf, Philipp Tobias Meyer, Martin Heuschkel, Maria Eveslage, Martin Bögemann, Wolfgang Peter Fendler and Bernd Joachim Krause

Journal of Nuclear Medicine January 1, 2017, 58 (1) 85-90; DOI: https://doi.org/10.2967/jnumed.116.183194
You have access
Response and Tolerability of a Single Dose of ¹⁷⁷Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Analysis
Kambiz Rahbar, Matthias Schmidt, Alexander Heinzel, Elisabeth Eppard, Axel Bode, Anna Yordanova, Michael Claesener and Hojjat Ahmadzadehfar

Journal of Nuclear Medicine September 1, 2016, 57 (9) 1334-1338; DOI: https://doi.org/10.2967/jnumed.116.173757

Main menu

User menu

Search

mCRPC